International Publisher of Science, Technology and Medicine

Share this
Track Your Manuscript
Journal of Biosimilars & Biowaivers
Editorial Board: Edmund J. Elder, PhD
 University of Wisconsin-Madison, USA  view all
Frequency: Quarterly
The Journal of Biosimilars & Biowaivers (JBSBW) promotes rigorous research that makes a significant contribution in advancing knowledge for Biosimilars. The journal includes all major themes pertaining to manufacturing process for biopharmaceuticals & waivers of clinical bioequivalence.
Biosimilars & Biowaivers is a subscription based journal that provides a range of options to purchase our articles and also permits unlimited Internet Access to complete Journal content. It accepts research, review papers, online letters to the editors & brief comments on previously published articles or other relevant findings in SciTechnol. Articles submitted by authors are evaluated by a group of peer review experts in the field and ensures that the published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate and reliable.